Category: NHS

agreement, analysis, analytics, Aussie, Australia, Australian, British, business, Business Analysis, CANADA, canadian, cannabinoid, cannabis, cbd, clinic, compliance, consumer, cooperation, cultivation, drug, England, Epidiolex, EU, europe, European, export, Federal, firm, German, Germany, global, government, growing, GW Pharma, GW Pharmaceuticals, healthcare, hospital, import, industry, insurance, insure, international, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, network, NHS, patient, pharmacies, pharmacy, pool, prescribe, prescription, producer, product, production, Quality, regulation, regulations, regulatory, retail, Sativex, state, thc, THC Global, UK, union, United Kingdom, wide, world

Will Australia’s Cannabis Program Follow Canada’s Lead?

Will Australia’s Cannabis Program Follow Canada’s Lead?

The news is intriguing in a world overwhelmed with pandemic news. THC Global, a Canadian-Aussie company now raising money and signing global […]

analysis, analytics, British, business, Business Analysis, CANADA, cannabidiol, cannabis, cbd, compliance, consumer, Coronavirus, COVID, COVID-19, cultivation, dispensary, EU, Euro, europe, export, extraction, Federal, government, growing, Home Office, import, industry, international, International Association for Cannabinoid Medicine, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, NHS, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, UK, United Kingdom

Navigating COVID-19 in the Cannabis industry in the UK

Navigating COVID-19 in the Cannabis industry in the UK

There is no doubt all industries are feeling the effects of the coronavirus pandemic; however, cannabis businesses face a unique set of challenges. […]